Cutaneous adverse drug reactionsA systematic approach is key to diagnosing and managing this complex range of conditions The Pharmacist’s guide to skin health from newborns to seniorsSkin health for all ages CLINICAL PEARLS: Use the ugly duckling sign to navigate a forest of moles New Drug: Picato for actinic keratosis New topical treatment is for non-hyperkeratotic, non-hypertrophic actinic keratosis in adults. Dermagraft for diabetic foot ulcers New product is for use in the treatment of full-thickness diabetic foot ulcers. New position statement on Diane-35 and VTE risk CLINICAL PEARLS: How to handle a fungal infection Apprilon: new once-daily oral therapy for rosacea Apprilon, marketed in the United States for several years under the brand name Oracea, is indicated for the treatment of inflammatory lesions of rosacea in adults. Keeping the itch at bay New clues into treating eczema Psoriasis doubles diabetes risk Researcher calls for annual screening in patients with the skin disease First Previous 59 60 61 62 63 Next Last
